Scientists Re-Examine old data to see which patients benefit from extra antibiotic for staph blood infection
NCT ID NCT07155590
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at data from two previous clinical trials involving 369 patients with Staphylococcus aureus bloodstream infections. Researchers want to see if adding the antibiotic fosfomycin to standard care helps certain patient groups more than others. They will classify patients by infection type and risk level to find who might benefit most. The goal is to improve treatment decisions for this serious infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fosfomycin
What this could lead to
If successful, this could help doctors identify which patients with staph bloodstream infections are most likely to benefit from adding fosfomycin to standard treatment.
What could go wrong
This is a post-hoc analysis, not a new trial, so results are less reliable. The original trials did not show consistent benefit, and the analysis may not have enough power to confirm findings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCAL AUREUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Catalonia, 08907, Spain
-
Hospital Universitario Virgen de Macarena
Seville, 41009, Spain